Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of antineoplaston therapy for stage III or stage IV prostate cancer was withdrawn, according to the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer | Phase 2 | Status: WITHDRAWN